Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
7.15
-0.05 (-0.69%)
Nov 18, 2026, 1:38 PM EST - Market open
Immix Biopharma Employees
Immix Biopharma had 21 employees as of December 31, 2025. The number of employees did not change compared to the previous year. That makes Immix Biopharma the 38,249th largest employer in the world and 5,455th in the United States.
Employees
21
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,202,795
Market Cap
599.26M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 21 | 0 | - | 21 | 0 |
| Dec 31, 2024 | 21 | 4 | 23.53% | 18 | 3 |
| Dec 31, 2023 | 17 | 6 | 54.55% | 14 | 3 |
| Dec 31, 2022 | 11 | 9 | 450.00% | 9 | 2 |
| Dec 31, 2021 | 2 | - | - | 2 | 0 |
| Sep 30, 2021 | 2 | - | - | 2 | 0 |
| Jun 30, 2021 | 2 | - | - | 2 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Geron | 258 |
| Alumis | 253 |
| 4D Molecular Therapeutics | 196 |
| DBV Technologies | 179 |
| Olema Oncology | 150 |
| Adlai Nortye Group | 109 |
| Bicara Therapeutics | 103 |
| Design Therapeutics | 60 |
IMMX News
- 5 hours ago - Immix Biopharma price target raised to $21 from $20 at Morgan Stanley - TheFly
- 6 hours ago - Immix Biopharma price target lowered to $22 from $23 at Mizuho - TheFly
- 2 days ago - Immix Biopharma price target raised to $27 from $25 at H.C. Wainwright - TheFly
- 5 days ago - Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress - GlobeNewsWire
- 6 days ago - Immix Biopharma Quarterly report: Q3 2026 - Filings
- 6 days ago - Immix Biopharma Earnings release: Q3 2026 - Filings
- 14 days ago - Immix Biopharma's NXC-201 NEXICART-2 Interim Clinical Trial Results Selected for Oral Presentation at ASH 2026 - GlobeNewsWire
- 20 days ago - Immix Biopharma price target lowered to $23 from $26 at Mizuho - TheFly